Genetic Characterization and Clinical Features of Helicobacter Pylori Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Barbara Kiesewetter,Christiane Copie-Bergman,Michael Levy,Fangtian Wu,Jehan Dupuis,Caroline Barau,Luca Arcaini,Marco Paulli,Marco Lucioni,Arturo Bonometti,Antonio Salar,Concepcion Fernandez-Rodriguez,Miguel A. Piris,Francesco Cucco,Rachel Dobson,Yan Li,Zi Chen,Cyrielle Robe,Ingrid Simonitsch-Klupp,Andrew Wotherspoon,Markus Raderer,Ming Qing Du
DOI: https://doi.org/10.3390/cancers13122993
2021-01-01
Cancers
Abstract:BACKGROUND:In Western countries, the prevalence of gastric mucosa-associated lymphoid tissue (MALT) lymphoma has declined over the last three decades. Contemporaneously, H. pylori negative gastric MALT lymphoma is increasingly encountered, and their genetic basis and clinical features remain elusive.METHODS:A total of 57 cases of H. pylori negative gastric MALT lymphoma were reviewed and investigated for chromosome translocation by fluorescence in-situ hybridization and for somatic mutations by the targeted sequencing of 93 genes.RESULTS:MALT1 translocation, most likely t(11;18)(q21;q21)/BIRC3-MALT1, was detected in 39% (22/57) cases, and IGH translocation was further seen in 12 MALT1-negative cases, together accounting for 60% of the cohort. Targeted sequencing was successful in 35 cases, and showed frequent mutations in NF-κB signaling pathways (TNFAIP3 = 23%, CARD11 = 9%, MAP3K14 = 9%), together affecting 14 cases (40%). The NF-κB pathway mutations were mutually exclusive from MALT1, albeit not IGH translocation, altogether occurring in 86% of cases. There was no significant correlation between the genetic changes and clinicopathological parameters. The patients showed a median of progression-free survival (PFS) of 66.3 months, and a significant superior PFS when treated with systemic versus antibiotic therapy (p = 0.004).CONCLUSION:H. pylori negative gastric MALT lymphoma is characterized by highly frequent genetic changes in the NF-κB signaling pathways.